Bone Loss Completed Phase 0 Trials for Denosumab (DB06643)

Back to Bone Loss

Also known as: Osteopenia / Osteopenia (disorder) / Osteopenia (morphologic abnormality) / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02554695Osteoclast Inhibition and Bone FormationBasic Science